Cargando…

Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy

Metastatic clear-cell renal cell carcinoma (ccRCC) affects thousands of patients worldwide each year. Antiangiogenic therapy has been shown to have beneficial effects initially, but resistance is eventually developed. Therefore, it is important to accurately track the response of cancer to different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rojas, Juan D., Lin, Fanglue, Chiang, Yun-Chen, Chytil, Anna, Chong, Diana C., Bautch, Victoria L., Rathmell, W. Kimryn, Dayton, Paul A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743465/ https://www.ncbi.nlm.nih.gov/pubmed/29290798 http://dx.doi.org/10.7150/thno.19658

Ejemplares similares

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018)

Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications
por: Wolf, Melissa M., et al.
Publicado: (2020)

SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition
por: Terzo, Esteban A., et al.
Publicado: (2019)

Correction: SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition
por: Terzo, Esteban A., et al.
Publicado: (2019)

3-D Ultrasound Localization Microscopy for Identifying Microvascular Morphology Features of Tumor Angiogenesis at a Resolution Beyond the Diffraction Limit of Conventional Ultrasound
por: Lin, Fanglue, et al.
Publicado: (2017)

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2015)

Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma
por: Ballesteros, Pablo Álvarez, et al.
Publicado: (2021)

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
por: Lim, Aaron R, et al.
Publicado: (2020)

Renal cell carcinoma
por: Jonasch, Eric, et al.
Publicado: (2014)

Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease
por: Chang, Emily Hueywen, et al.
Publicado: (2017)

Blood Vessel Patterning on Retinal Astrocytes Requires Endothelial Flt-1 (VEGFR-1)
por: Chappell, John C., et al.
Publicado: (2019)

Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine
por: Zhang, Cheng, et al.
Publicado: (2018)

Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study
por: Abuzenadah, Adel M., et al.
Publicado: (2022)

A defined clathrin-mediated trafficking pathway regulates sFLT1/VEGFR1 secretion from endothelial cells
por: Kinghorn, Karina, et al.
Publicado: (2023)

Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies
por: Rathmell, Kimryn W., et al.
Publicado: (2015)

Antiangiogenic Therapy in Clear Cell Renal Carcinoma (CCRC): Pharmacological Basis and Clinical Results
por: Comandone, Alessandro, et al.
Publicado: (2021)

HIF1α and HIF2α Exert Distinct Nutrient Preferences in Renal Cells
por: Arreola, Alexandra, et al.
Publicado: (2014)

Antiangiogenic Effect of Ethanol Extract of Vigna angularis via Inhibition of Phosphorylation of VEGFR2, Erk, and Akt
por: Kwon, Oh Sung, et al.
Publicado: (2015)

Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF-VEGFR2-AKT/FAK signal axis
por: Wang, Xinzhi, et al.
Publicado: (2017)

Antiproliferative and Antiangiogenic Properties of New VEGFR-2-targeting 2-thioxobenzo[g]quinazoline Derivatives (In Vitro)
por: Abuelizz, Hatem A., et al.
Publicado: (2020)

Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity
por: Zanjanchi, Pegah, et al.
Publicado: (2022)

Notch regulates the angiogenic response via induction of VEGFR-1
por: Funahashi, Yasuhiro, et al.
Publicado: (2010)

VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma
por: Lkhagvadorj, Sayamaa, et al.
Publicado: (2014)

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

COVID-19 impact on early career investigators: a call for action
por: Levine, Ross L., et al.
Publicado: (2020)

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
por: Kinget, Lisa, et al.
Publicado: (2021)

Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma
por: An, Hyo Jung, et al.
Publicado: (2019)

Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways
por: Li, Grace X., et al.
Publicado: (2021)

Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
por: Elmeligie, Salwa, et al.
Publicado: (2019)

Ultrasound Molecular Imaging of Renal Cell Carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles
por: Ingels, Alexandre, et al.
Publicado: (2020)

The therapeutic implications of immunosuppressive tumor aerobic glycolysis
por: Reinfeld, Bradley I., et al.
Publicado: (2021)

Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis
por: Hultgren, Nan W., et al.
Publicado: (2020)

BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model
por: Courcier, Jean, et al.
Publicado: (2023)

The Performance of Flash Replenishment Contrast-Enhanced Ultrasound for the Qualitative Assessment of Kidney Lesions in Patients with Chronic Kidney Disease
por: Walmer, Rachel W., et al.
Publicado: (2023)

Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell–Renal-Cell-Carcinoma: Proof-of-Concept Study
por: Yin, Qingbo, et al.
Publicado: (2017)

The Biological-Behavioral Effect Of Neuritin On Non-Small Cell Lung Cancer Vascular Endothelial Cells Via VEGFR And Notch1
por: Zhang, Qiao, et al.
Publicado: (2019)

VHL Type 2B Mutations Retain VBC Complex Form and Function
por: Hacker, Kathryn E., et al.
Publicado: (2008)

PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI–Resistant Metastatic Clear Cell Renal Cell Carcinoma
por: Jeong, Se Un, et al.
Publicado: (2023)

Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response
por: DeSimone, Michelle C., et al.
Publicado: (2013)

YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models
por: Xia, Yong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tmu9a3t4vbhn11rk7lp3cb7e68